Treatment of Residual Amblyopia With Donepezil

PHASE1CompletedINTERVENTIONAL
Enrollment

18

Participants

Timeline

Start Date

August 31, 2012

Primary Completion Date

January 31, 2021

Study Completion Date

January 31, 2021

Conditions
Amblyopia
Interventions
DRUG

Donepezil

"Oral Donepezil Daily~Initial Dosage: Donepezil 5 mg tablets will be used. 1/2 tablet (≈2.5 mg)/day for 8 to 17 year olds OR 1 tablet (5 mg)/day for ≥18 year olds.~Dosage Escalation: Donepezil may be increased by 1/2 tablet (≈2.5 mg)/day every 4 weeks if the amblyopic eye visual acuity has not improved by ≥5 letters or 1 logMAR line to a maximum dosage of 1 1/2 tablets (≈7.5 mg)/day for 8 to 17 year olds OR 2 tablets (10 mg)/day for ≥18 year olds."

OTHER

Patching

Patching: 2 hours of daily patching will also be prescribed for 8 to 17 year olds only.

Trial Locations (3)

02115

Boston Children's Hospital, Boston

02453

Boston Children's Hospital at Waltham, Waltham

02190

Boston Children's Physicians South, Weymouth

All Listed Sponsors
lead

Boston Children's Hospital

OTHER

NCT01584076 - Treatment of Residual Amblyopia With Donepezil | Biotech Hunter | Biotech Hunter